Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.56 |
| ▸ | MAOB | P27338 | 6/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | PPOX | P50336 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 2/20 | 0.55 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | PRKCG | P05129 | 1/20 | 0.55 |
| ▸ | PRKCB | P05771 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
| ▸ | PRKCH | P24723 | 1/20 | 0.55 |
| ▸ | PRKCI | P41743 | 1/20 | 0.55 |
| ▸ | ABL2 | P42684 | 1/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.55 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30828317 | 1.00 | MAOA (0.56) | MAOAMAOBESR1UGT1A1ESR2 | |
| Benzaldehyde SCHEMBL29253163 | 0.82 | ALDH1A1 (0.48) | MAOAMAOBESR1EGFRPRKD3 | |
| SCHEMBL383829 | 0.76 | MAOA (0.63) | MAOAMAOBPPOXCA1CA2 | |
| SCHEMBL8319902 | 0.75 | PPOX (0.60) | MAOAMAOBPPOXGSK3BCYP3A4 | |
| SCHEMBL8962219 | 0.75 | PPOX (0.60) | MAOAMAOBPPOXGSK3BCYP3A4 | |
| Potassium SCHEMBL31268252 | 0.74 | MAOA (0.61) | MAOAMAOBPPOXCA1CA2 | |
| SCHEMBL11426691 | 0.74 | MAOA (0.61) | MAOAMAOBPPOXCA1CA2 | |
| SCHEMBL11435308 | 0.74 | MAOA (0.61) | MAOAMAOBPPOXCA1CA2 | |
| SCHEMBL11422269 | 0.74 | MAOA (0.61) | MAOAMAOBPPOXCA1CA2 | |
| Lithium SCHEMBL11426699 | 0.74 | MAOA (0.61) | MAOAMAOBPPOXCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290915-B | Heat-resistant PET protective film and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118290915-A | Heat-resistant PET protective film and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-103896822-B | A kind of 3, the synthetic method of the two phthalic imidine of 4 '-oxo | YIZHENG HAIFAN CHEMICAL CO., LTD. (CN) | 2016-02-10 | — | — | CN | claimed |
| CN-103896822-A | Synthetic method of 3, 4'-oxo bisphthalimide | YIZHENG HAIFAN CHEMICAL CO LTD | 2014-07-02 | — | — | CN | claimed |
| EP-0195402-B1 | BIS(HYDROXYPHTHALIMIDE) AND PROCESS FOR PREPARING THE SAME, AND PROCESS FOR PREPARING POLYESTERIMIDE BY THE USE THEREOF | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1992-06-10 | — | — | EP | claimed |
| US-4207112-A | STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1980-06-10 | — | — | US | claimed |
| JP-10147064-A | — | — | None | — | — | JP | disclosed |
| CN-121574723-A | Application of pomalidomide and various derivatives thereof as electrochemiluminescence probes | 厦门医学院 | 2026-02-27 | — | — | CN | disclosed |
| US-12251370-B2 | Small molecule inhibitors of the BfrB:Bfd interaction | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2025-03-18 | — | — | US | disclosed |
| US-20240327412-A1 | FACTOR XIIA INHIBITORS | KALVISTA PHARMACEUTICALS LIMITED (GB) | 2024-10-03 | — | — | US | disclosed |
| CN-118290915-B | Heat-resistant PET protective film and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118290915-A | Heat-resistant PET protective film and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-11912699-B2 | Tau-protein targeting compounds and associated | ARVINAS OPERATIONS, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-5821256-A | Endothelin receptor antagonists | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1998-10-13 | — | — | US | disclosed |
| JP-H10147064-A | REVERSIBLE HEAT-SENSITIVE COLORING COMPOSITION AND REVERSIBLE RECORDING MEDIUM USING THE SAME | RICOH CO LTD | 1998-06-02 | — | — | JP | disclosed |
| EP-0758650-A1 | Endothelin receptor antagonists | MERCK PATENT GmbH (DE) | 1997-02-19 | — | — | EP | disclosed |
| US-5208364-A | Antiinflammatory agents of amines with carboxy, oxy groups | BRISTOL-MYERS SQUIBB CO. (US) | 1993-05-04 | — | — | US | disclosed |
| US-4207112-A | STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1980-06-10 | — | — | US | disclosed |
| US-4144072-A | CONTAINING A PHTHALAZINONE AND A PHTHALIMIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-03-13 | — | — | US | disclosed |
| US-3933507-A | LIGHT INSENSITIVE SILVER SALT, POLYMETHINE SENSITIZER | AGFA-GEVAERT, A.G. (DT) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912699-B2 | Tau-protein targeting compounds and associated | MAPT, VHL, CRBN | MAOA 2592/4885MAOB 2985/4885ESR1 2710/4885 |
| US-12251370-B2 | Small molecule inhibitors of the BfrB:Bfd interaction | BLVRB, TFPI, ETFB | MAOA 787/4885MAOB 292/4885ESR1 2734/4885 |
| US-20240327412-A1 | FACTOR XIIA INHIBITORS | F11, F13B, F12 | MAOA 219/4885MAOB 102/4885ESR1 4135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.